Fig. 5

Genera with significant abundance between cancer patients at pre-treatment (P) and treatment (T) adjusted by GI symptoms and control. Genera with altered relative abundance in cancer patients by pairwise comparison between two groups was marked as asterisk for significant differences based on Wilcoxon rank sum test (*p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001).